Uncategorized
Regeneron reports $1.1 billion in revenue in third quarter
Regeneron reported $1.1 billion in total revenue in the third quarter compared with $726 million in the same quarter of 2014, according to a press release. The increase was partially attributed to an increase in net profit from commercialization of Eylea (aflibercept) outside of the U.S.